Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > I see $20 per stock

<< Previous

Bullboard Posts

Next >>

Comment by MedStocks2on Jan 16, 2021 3:36am

416 Views

Post# 32312651

RE:RE:I see $20 per stock

exactly fog. Cearly West Van knows nothing about this company. Everyone here realizes that with the immune tech, this will fly through approval for all type 1 and type 2 insulinlin dependent diabetics. Add to that the list of diseases that can be moderated or cured through cell therapy.

<< Previous

Bullboard Posts

Next >>

The top TSX healthcare stocks under $1